These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23518210)

  • 1. Time trends in survival from cancer of unknown primary: small steps forward.
    Riihimäki M; Hemminki A; Sundquist K; Hemminki K
    Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M; Rutqvist LE; Johansson H
    Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific survival rates for cancer of unknown primary according to location of metastases.
    Hemminki K; Riihimäki M; Sundquist K; Hemminki A
    Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden.
    Shu X; Sundquist K; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 May; 21(3):281-8. PubMed ID: 21968687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site.
    Riihimäki M; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2014 Jun; 14():439. PubMed ID: 24929562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
    Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
    Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
    Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
    Hemminki K; Bevier M; Sundquist J; Hemminki A
    Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
    Bevier M; Sundquist J; Hemminki K
    Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in cancer of unknown primary site: population-based analysis by site and histology.
    Hemminki K; Bevier M; Hemminki A; Sundquist J
    Ann Oncol; 2012 Jul; 23(7):1854-63. PubMed ID: 22115926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
    Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
    Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
    Shaw PH; Adams R; Jordan C; Crosby TD
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.
    Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J
    Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
    Liu H; Hemminki K; Sundquist J; Holleczek B; Katalinic A; Emrich K; Brenner H;
    Eur J Cancer Prev; 2013 May; 22(3):210-4. PubMed ID: 22960777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.
    Worni M; Guller U; White RR; Castleberry AW; Pietrobon R; Cerny T; Gloor B; Koeberle D
    Pancreas; 2013 Oct; 42(7):1157-63. PubMed ID: 23867367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.
    Binder C; Matthes KL; Korol D; Rohrmann S; Moch H
    Cancer Med; 2018 Sep; 7(9):4814-4824. PubMed ID: 30019510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
    Pentheroudakis G; Golfinopoulos V; Pavlidis N
    Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence patterns of small bowel cancer in a population-based study in Sweden: increase in duodenal adenocarcinoma.
    Lu Y; Fröbom R; Lagergren J
    Cancer Epidemiol; 2012 Jun; 36(3):e158-63. PubMed ID: 22405637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Holmberg L
    Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid reduction in the incidence of cancer of unknown primary. A population-based study.
    Brustugun OT; Helland Å
    Acta Oncol; 2014 Jan; 53(1):134-7. PubMed ID: 23550957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.